8 min. Read

FDA sleeps on AI/ML guidance. Google buys Fitbit for $2.1B

Issue 026. Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a glass-is-half-full 56 percent open rate. Here's what's happening this week:

  • Have you read that Google is acquiring Fitbit for $2.1 billion? More on that below. This has been the newsiest week of 2019, so I'll try to keep these brief as this issue is now over-stuffed.
  • Stat reports that later today President Trump is expected to nominate MD Anderson's chief medical executive Stephen Hahn as the next FDA commissioner.
  • A trio of Democrat Senators sent another letter to the FDA loaded with questions and concerns about the way Pre-Cert will work. Read the latest letter here. Their letter from October 2018 here. And the FDA's June 2019 response to the first letter here.
  • The Unbearable Lightness of De-identified Data: The concept of "de-identified patient data" eroded

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Facebook’s RCT for AI bot Zenny. More trials
7 min. Read
FDA de novo for Google smartphone thermometer.
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
6 min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
5 min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
6 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last